Dr Amina Haouala joined the COVID-19 Clinical Research Coalition as Coordinator in July 2022.

She has over 10 years of experience in public and global health. As a clinical scientist, she worked in the development of new antimalarial treatments at the University of Geneva in collaboration with the National Institute of Public Health Research of Mali, and at the product development partnership Medicines for Malaria Venture (MMV). She was also involved in the development of new therapeutics for the treatment of cancer and infectious diseases at Debiopharm. Before joining the Coalition, she coordinated portfolio programs and clinical projects to develop new medicines and advance research at MMV and Unisanté.

Dr Amina Haouala graduated as PharmD from the University of Geneva and holds a PhD in Clinical Pharmacology from the University Hospital of Lausanne.